Stockreport
United States Liquid Biopsy Market Analysis Report 2024: A $3.68 Billion Industry by 2032 from $1.06 Billion in 2023 - Emphasis on Companion Diagnostics, Increasing acceptance of Non-invas...
Last illumina, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations: illumina.com/company/investor-information.html
types, Products, Application, Biomarkers, Sample types, End-Users, and Company Analysis 2024-2032" report has been added to ResearchAndMarkets.com's offering. The United States Liquid Biopsy Market value is foreseen to be around US$ 3.68 Billion by 2032. The CAGR for the market from 2024 to 2032 is 14.83%. The analyst states that it amounted to US$ 1.06 Billion in 2023. Liquid biopsy is prevalent in healthcare. It is non-invasive and detects biomarkers in blood or urine. This innovative diagnostic approach gives a much less worrying alternative to traditional tissue biopsies. It is mainly used for cancer detection and tracking. Its versatility extends past oncology, with programs in prenatal testing, infectious illnesses, and organ transplant monitoring. Liquid biopsy revolutionizes the care of patients and provides well-timed and personalized remedy strategies. This is because of ongoing improvements in technology and research. Cancer is a global pandemic. The NIH expected that
[Read more]
IMPACT SNAPSHOT | EVENT TIME: | ILMN | ||||
---|---|---|---|---|---|---|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
LAST PRICE | ||
VWAP | ||
High:
|
MAX UP |
High:
|
Low:
|
MAX DOWN |
Low:
|
%
|
POST NEWS RANGE |
%
|
|
PRICE CHANGE |
|
|
PRICE CHANGE PERCENTAGE |
|
|
S&P 500 (SPX) |
|
%
|
VOLUME RATIO |
%
|
VOLUME (SHARES) | ||
TICKS | ||
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
ILMN alerts
ILMN alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
ILMN alerts
High impacting Illumina, Inc. news events
Weekly update
A roundup of the hottest topics
ILMN
NEWS
NEWS
- Metagenomics Market Size, Share & Trends Analysis Report 2024-2030: Emergence of New Fields in Genomics that Complement Metagenomics Fueling Expansion [Yahoo! Finance][Yahoo! Finance]
- GRAIL to Host Capital Markets Day [Yahoo! Finance][Yahoo! Finance]
- GRAIL to Host Capital Markets Day[Business Wire]
- Illumina, Inc. (NASDAQ: ILMN) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.[MarketBeat]
- Rapid Growth of Biotechnology and Pharmacogenomics is Stimulating the Growth of the Global Personalized Medicines Market; says TNR, The Niche Research [Yahoo! Finance][Yahoo! Finance]
- More
ILMN
SEC Filings
SEC Filings
- 5/8/24 - Form 4
- 5/8/24 - Form 4
- 5/3/24 - Form 8-K/A
- ILMN's page on the SEC website
- More